Fundz

Efemoral Medical reported raising $525,000 in an initial SEC Form D filing, from an offering of $3 Million

PRIVATEJun 16, 2023$525K of $3M raised

Amount Raised

$525,000

$525,000 sold, per SEC Form D (first sale Jun 12, 2023)

Round Type

Series A

Los AltosBiotechnology

Quick answer

Efemoral Medical raised $525,000 in a Series A round, dated June 12, 2023. Efemoral Medical is based in Los Altos, California, United States.

How much did Efemoral Medical raise?
Efemoral Medical raised $525,000 in a Series A round on June 12, 2023.
What does Efemoral Medical do?
Efemoral Medical, Inc. is developing next-generation bioresorbable solutions to treat patients with vascular disease.
Where is Efemoral Medical based and how big is it?
Efemoral Medical is based in Los Altos, California, United States.
Who are the decision-makers at Efemoral Medical?
Fundz holds 1 contact at Efemoral Medical, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Efemoral Medical that raised within 45 days of this round, from Fundz verified event records.

  • Quadrant Biosciences Inc raised $3.5M (Seed) on July 27, 2023.
  • Better Therapeutics raised $2.1M (Seed) on July 27, 2023.
  • Octave Bioscience raised an undisclosed amount (Funding Round) on July 26, 2023.
  • Kriya Therapeutics raised an undisclosed amount (Series C) on July 26, 2023.
  • Nexo Therapeutics raised $60M (Series A) on July 26, 2023.
  • Octave Bioscience raised $30M (Series B) on July 26, 2023.

Who to call at Efemoral Medical, and when

A new round usually means Efemoral Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Efemoral Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Efemoral Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Efemoral Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Efemoral Medical

Location

2300 DEODARA DRIVE

Los Altos, California, United States

About

Efemoral Medical, Inc. is developing next-generation bioresorbable solutions to treat patients with vascular disease. The company's initial product, the Efemoral Vascular Scaffold System (EVSS) with FlexStep Technology, is designed to offer a dedicated strategy for PAD interventions. The Efemoral Vascular Scaffold System (EVSS) is an OUS Investigational Device only. To learn more, please visit efemoralmedical.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Efemoral Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsChris H., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Efemoral Medical's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Efemoral Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.